Catapano, Alberico L.

Cholesterol Lowering Biotechnological Strategies: From Monoclonal Antibodies to Antisense Therapies. A Pre-Clinical Perspective Review

Bellosta, S., Rossi, C., Alieva, A. S., Catapano, A. L., Corsini, A., & Baragetti, A. (2023) · Cardiovascular Drugs and Therapy

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 10

Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry

D’Erasmo, L., Tramontano, D., Di Costanzo, A., Casula, M., Galimberti, F., Baratta, F., Cefalù, A. B., Tarugi, P. M., Calandra, S., Zambon, A., et al. (2025) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 9

Fibrates : Do They Still Have a Role in Therapy in 2025?

Pirillo, A., Zambon, A., & Catapano, A. L. (2025) · Current Atherosclerosis Reports

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 4

Effects of fibrates on lipid profile: a meta-analysis of randomized controlled trials

Olmastroni, E., Galimberti, F., Xie, S., Casula, M., & Catapano, A. L. (2025) · European Atherosclerosis Journal

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 4

Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort

Arca, M., Calabrò, P., Solini, A., Pirillo, A., Gambacurta, R., Ray, K. K., & Catapano, A. L. (2026) · Nutrition, Metabolism and Cardiovascular Diseases

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3

81Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis

Awad, K., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Moriarty, P., Lip, G. Y. H., Muntner, P., Catapano, A. L., Pencina, M. J., Rosenson, R. S., et al. (2017) · European Heart Journal

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 2

Effect of angiopoietin-like protein 3 inhibitors on lipid profile and other biomarkers: a meta-analysis of randomized controlled trials

Xie, S., Galimberti, F., Olmastroni, E., Catapano, A. L., & Casula, M. (2026) · European Journal of Preventive Cardiology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 0